BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

Highlights Biohaven Pharmaceutical Holding Company Ltd.

Equities

BHVN

VGG111961055

Market Closed - Nyse Other stock markets 21:00:01 09/05/2024 BST			5-day change	1st Jan Change
41.36 ^USD	+1.42%		+3.66%	-72.75%

04-25	Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	MT
04-23	Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	04-18	MT
Biohaven Prices $230 Million Public Share Offering	04-18	MT
Biohaven Q4 Non-GAAP Net Loss Widens, Shares Fall After-Hours	02-29	MT
Biohaven Pharmaceutical Q3 Net Loss Narrows	11-14	MT
Biohaven Completes Enrollment in Spinal Muscular Atrophy Phase 3 Study of Taldefgrobep Alfa	14/09/23	MT
Biohaven Narrows Q2 Non-GAAP Loss; Gets Orphan Drug Label for Taldefgrobep Alfa in Europe	31/07/23	MT
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'	11/05/23	RE
Biohaven Purchases License to Develop BHV-8000 for Treatment of Immune-Mediated Brain Disorders	22/03/23	MT
Biohaven Ltd. Acquires Exclusive License for Oral, Brain-Penetrant, Dual TYK2/JAK1 Inhibitor for Immune-Mediated Brain Disorders	22/03/23	CI
Biohaven Granted US FDA Fast Track Designation for Spinal Muscular Atrophy Treatment Candidate	21/02/23	MT
Biohaven's Q3 Adjusted Loss Widens	09/11/22	MT
Earnings Flash (BHVN) BIOHAVEN Reports Q3 Loss $-1.25	09/11/22	MT
Pfizer Closes $11.6 Billion Biohaven Pharmaceutical Buyout	03/10/22	MT
Biohaven Pharmaceutical Holding Company Ltd. completed the Spin-Off of Biohaven Ltd..	02/10/22	CI
Pfizer Inc. completed the acquisition of the remaining 97.1% stake in Biohaven Pharmaceutical Holding Company Ltd. from BlackRock, Inc. and others.	02/10/22	CI
Biohaven Pharmaceutical Holding Company Ltd. Provides Update from Pivotal Phase 2/3 Trial with Verdiperstat in Amyotrophic Lateral Sclerosis (Healy Als Platform Trial)	29/09/22	CI
Biohaven Pharmaceutical's Acquisition by Pfizer Likely to Close Oct. 3	27/09/22	MT
Biohaven Pharmaceutical : Update Regarding Litigation Related to the Merger and Spin-Off - Form 8-K	23/09/22	PU
Biohaven Pharmaceutical Holding Sets Sept. 26 Record Date for Biohaven Ltd. Spin-Off	19/09/22	MT
Biohaven Announces Record Date for Anticipated Spin-Off	19/09/22	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biohaven Pharmaceutical Holding Company Ltd.

Equities

BHVN

VGG111961055

Highlights

Filters